Loading stock…

Alibaba Health Information Technology Limited (241) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Alibaba Health Information Technology Limited

241Market cap $5.81BPrice $0.4

Country🇨🇳China

SectorConsumer

IndustryConsumer Staples

Runs China's largest online pharmacy, selling medicine, health products, and medical services to hundreds of millions of consumers. Backed by Alibaba's logistics and data, it's turning prescription refills into an e-commerce battleground bigger than most hospitals combined.

In Bastion Portfolios?

52W Return-53%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+8%6

Revenue Forecast

Rev CAGR (1y)+12%7

Rev CAGR (3y)+10%7

Rev CAGR (5y)+9%7

Earnings Forecast

EPS Growth Y+1+15%7

EPS Growth Y+2+14%7

EPS Growth Y+3+17%8

Quality

Margins

EBIT Margin5%3

Net Income Margin6%4

Free Cash Flow Margin4%4

Debt

Net Debt/EBITDA-5.410

Efficiency

ROE11%5

ROA9%8

Earnings Stability1010

GEAR+AVERAGE58

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)185

P/E Ratio (Forward 3y)145

P/BV2.26

EV Multiples

EV/EBITDA Fwd106

EV/EBIT Fwd118

Yield

Free Cash Flow Yield3.2%5

Dividend Yieldna–

Momentum

Short term

1 month return-10%2

3 month return-14%3

YTD return-41%1

Mid term

Price vs 52wHigh38%1

1 year return-55%1

Long term

3 year return-37%1

5 year return-74%1

Risk Shield

Price Risk

Beta1.52

Volatility42%4

Free Cash Flow

Free Cash Flow Margin4%4

Free Cash Flow Yield3.2%5

Quality

ROCE11%6

Earnings Stability1010

Net Debt/EBITDA-5.410

02Growth

Is it actually growing, and how fast?

241Alibaba Health Information Technology

Revenue FY26$5.0B

GROWTH RATING↗

STRONG68 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+8%6

Revenue, next 1Y+12%7

Revenue, next 3Y, CAGR+10%7

Revenue, next 5Y, CAGR+9%7

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+15%7

EPS growth, FY28E+14%7

EPS growth, FY29E+17%8

GROWTH ASSESSMENT

STRENGTHS

It out-grows 68% of companies worldwide.

Revenue is set to grow 10%/yr over the next 3 years, ahead of most of the market.7/10

Revenue grew 8%/yr over the last 3 years and is set to keep growing around 10%/yr.

The runway holds up: revenue is set to grow 9%/yr over five years.7/10

Earnings are set to grow in step with sales (EPS about 15%/yr vs revenue 10%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Grower

A top-tier grower.

03Price Momentum

Is the market behind it right now?

241Alibaba Health Information Technology

Total return Current−20.2%

Price return Current−20.2%

MOMENTUM RATING↗

VERY WEAK3 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-10%2

3-month return-14%3

YTD return-41%1

MID & LONG-TERM▾SCORE

% of 52-week high38%1

1-year return-55%1

3-year return-37%1

5-year return-74%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-37% over three years and -74% over five), behind 90% of the market.

It's down 55% over the past year, now 62% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-10%), over three months (-14%) and so far this year (-41%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Alibaba Health. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

241Alibaba Health Information Technology

Revenue FY26$5.0B

GROWTH RATING↗

STRONG68 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+8%6

Revenue, next 1Y+12%7

Revenue, next 3Y, CAGR+10%7

Revenue, next 5Y, CAGR+9%7

EARNINGS FORECAST▾SCORE

EPS growth, FY27E+15%7

EPS growth, FY28E+14%7

EPS growth, FY29E+17%8

GROWTH ASSESSMENT

STRENGTHS

It out-grows 68% of companies worldwide.

Revenue is set to grow 10%/yr over the next 3 years, ahead of most of the market.7/10

Revenue grew 8%/yr over the last 3 years and is set to keep growing around 10%/yr.

The runway holds up: revenue is set to grow 9%/yr over five years.7/10

Earnings are set to grow in step with sales (EPS about 15%/yr vs revenue 10%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Steady Grower

A top-tier grower.

03Price Momentum

Is the market behind it right now?

241Alibaba Health Information Technology

Total return Current−20.2%

Price return Current−20.2%

MOMENTUM RATING↗

VERY WEAK3 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-10%2

3-month return-14%3

YTD return-41%1

MID & LONG-TERM▾SCORE

% of 52-week high38%1

1-year return-55%1

3-year return-37%1

5-year return-74%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-37% over three years and -74% over five), behind 90% of the market.

It's down 55% over the past year, now 62% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-10%), over three months (-14%) and so far this year (-41%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Alibaba Health. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community